611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
COVID Is Proving More Lethal for Children in Africa3 Reasons Why Trying to Get COVID Is a Bad IdeaFree N95 Masks Begin Arriving in U.S. PharmaciesOmicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level OffFDA Limits Use of Two COVID Antibody TreatmentsCOVID Can Affect Brains of Hospitalized KidsCOVID Vaccine Hesitancy Falling Faster Among Black Americans Than WhitesEngland to Lift Travel Restrictions for Vaccinated VisitorsAre Pins or a Cast Better for a Broken Wrist?FDA May Limit Use of Two COVID Antibody TreatmentsSome Patients With Macular Degeneration Could Stop Monthly Eye InjectionsYou Don't Have to Smoke to Get Lung CancerCOVID Vaccine Won't Affect Fertility, But Getting COVID MightThree New Studies Confirm Power of Booster Shots Against OmicronHit Your Head? Look for These Warning Signs of ConcussionArthritis & the COVID Vaccine: What You Need to KnowCOVID Boosters Keep Older Americans Out of Hospitals: CDCCOVID Rapid Test Makers Struggling to Meet DemandAHA News: A Healthy Thyroid Can Be Key to a Healthy HeartAnother Study Finds Vaccine Booster 'Neutralizes' Omicron'Artificial Pancreas' Can Help Kids With Type 1 DiabetesGetting Back to Sports After Recovering from COVID-19Side Effects From New Cancer Meds Have Silver LiningDengue Virus Makes Mosquitoes Bite More OftenNew Clues to Why Some Develop 'Brain Fog' After COVIDVaccination Plus Prior Infection Best Defense Against COVIDBinge-Watching Could Raise Your Blood Clot RiskIs a Night in the Hospital Necessary After Hip, Knee Replacement?Crowded Emergency Rooms Cost Lives: StudyCOVID Restrictions Eased in EnglandNo Side Effects From Your COVID Vaccine? Don't Worry, It's Still WorkingNearly Half of Americans Gained Weight in Pandemic's First YearNo Evidence Breastfeeding Can Transmit CoronavirusWHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities ErasedBiden Plans to Send 400 Million N95 Masks to Americans for FreeHeart Function Rebounds for Kids With COVID-Linked MIS-CAHA News: What Heart and Stroke Patients Need to Know About COVID-19 in 2022Which Kids Are Most Vulnerable to Severe COVID-19?Vaping Might Worsen COVID-19 SymptomsToo Soon to Tell if Omicron Will End Pandemic: FauciWhite House Launches Website for Free Home COVID Tests One Day Ahead of SchedulePolitics Clouds Folks' Views on COVID Rules, Global Survey ConfirmsCOVID-19 Treatments: What You Need to KnowAt-Home COVID Tests Accurate for Ki​ds: StudyHere's How to Get Your Free Home COVID Test KitsInsurance Often Covers Ivermectin for COVID, Even Though Drug Doesn't WorkCOVID Cases Surge Again in U.S. Nursing HomesCBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists SayCarbon Monoxide Deaths Soar During Power OutagesAHA News: Transplanting Pig Hearts Into Humans Offers Promise – and Peril
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Study Finds Delta Somewhat Resistant to Vaccines — What About Omicron?

HealthDay News
by By Dennis Thompson HealthDay Reporter
Updated: Dec 3rd 2021

new article illustration

FRIDAY, Dec. 3, 2021 (HealthDay News) -- Lab studies show that the mutations found in COVID-19's Delta variant make the virus more resistant to existing vaccines, a potentially ominous development as the new Omicron variant starts to wend its way around the world.

Full vaccination with the Pfizer or AstraZeneca vaccines still produces enough antibodies to neutralize Delta, British researchers found.

But the Delta variant put up a stronger fight against antibody protection than earlier versions of COVID-19.

"As Omicron has multiple mutations, some of which are in the same areas of the viral surface protein as the Delta variant, we would expect the Omicron variant to have reduced sensitivity to neutralization," said senior researcher Brian Willett, a professor of viral immunology with the MRC-University of Glasgow Center for Virus Research in Scotland.

For this study, the researchers analyzed blood samples collected from healthy people who had received either the Pfizer or AstraZeneca vaccine. The AstraZeneca shot is approved for use in the United Kingdom but not in the United States.

The samples came from 156 people who had received either the full two-dose course of either vaccine, or just got one dose.

The researchers exposed the blood samples to different COVID-19 variants to see how effectively vaccine-produced antibodies would fight off each coronavirus strain.

The vaccines provided protection against all COVID-19 variants, but the investigators noted that antibodies struggled more to stop them.

In particular, the Delta variant caused a fourfold reduction in the immune response of people who got the Pfizer vaccine and a fivefold reduction in AstraZeneca vaccine recipients.

"The positive news is that all of the variants tested were neutralized by the (antibodies) from the vaccinated individuals, so we would predict that immunity elicited by vaccination with two doses of the existing vaccines would extend to the variants," Willett said.

"However, it may not be as effective as it was against the viruses circulating previously, i.e., the virus of the first wave or the subsequent Alpha variant," he continued. "Similarly, as antibody responses to coronaviruses wane over time, the duration of immunity may be shortened. Hence, this is why boosters are now being offered in the U.K. after a three-month gap rather than the initial, advised six-month gap."

The United States now makes booster doses available to people who got the Pfizer or Moderna vaccine at least six months after finishing their two-dose series, or at least two months after getting the Johnson & Johnson single-dose shot.

The U.K. lab results are not entirely surprising given what we've learned about COVID-19 variants, said Dr. William Schaffner, medical director of the Bethesda, Md.-based National Foundation for Infectious Diseases.

"With the accumulation of mutations, you can get some reduction in effectiveness of our current vaccines. That's the general principle," Schaffner said. "It's not a shock, but here it's been demonstrated, and we think it is likely it will apply to Omicron as well, particularly since Omicron has even more mutations related to the spike protein."

The good news, Schaffner said, is that there is partial protection and he anticipates that with Omicron as well.

People concerned about either Delta or Omicron should get fully vaccinated and then boosted for maximum protection, Schaffner and Willett said.

"By boosting, we increase the level of antibodies in circulation to a high level and this should provide a degree of cross-protective immunity against not only the vaccine strain — the first wave virus — but also the variants such as Delta," Willett said.

The findings were published online Dec. 2 in the journal PLOS Pathogens.

More information

The U.S. Centers for Disease Control and Prevention has more about COVID-19 variants.

SOURCES: Brian Willett, PhD, professor, viral immunology, MRC-University of Glasgow Center for Virus Research, Scotland; William Schaffner, MD, medical director, National Foundation for Infectious Diseases, Bethesda, Md.; PLOS Pathogens, Dec. 2, 2021, online